Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by moonball32on Mar 23, 2022 3:48pm
119 Views
Post# 34538988

RE:RE:RE:RE:It's over

RE:RE:RE:RE:It's overAgreed, a fluff NR serves absolutely no purpose at this , if ever, but with the companies wishy washy time references (ie. Last one stating "very soon" ) they need to precise and cut all the bs promises. Investors sentiment and support is on its last legs, I understand making sure all the T's and I's are dotted, but really 6, maybe 7 weeks to do it seems excessive. Unless the original application has had material changes done to it, including proven clinical study data should not take 7 weeks. FIA promised revenue by end of Q1, the clock is ticking very loudly regarding that statement now.
<< Previous
Bullboard Posts
Next >>